FDA Inspection 1234677 — Amerisource Bergen Drug Corporation
The FDA completed an inspection of Amerisource Bergen Drug Corporation on March 22, 2024 in Phoenix, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 22, 2024
- Fiscal Year
- 2024
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Phoenix, AZ (United States)